Introduction to moderate sedation
Procedural Burden Pain and/or Fear and/or Anticipatory Anxiety
|Pre-medication||Emergency||MRI, CT scans||Fibroscopy, Endoscopy||Dental|
The formulation was developed at the Amiens Hospital in France, with the help of an Anaesthesiologist and a Hospital Pharmacist.
Innovation – OZALIN® / OZASED®
Launch OZALIN®*as an oral paediatric sedative licensed and approved in EU.
- Launching in 2020-2022 across EU.
- Utilising a mix or Primex own teams and partners across EU.
- Expand with the submission of regulatory files for international markets.
(Supported by an unrestricted educational grant from Primex Pharmaceuticals)
Safetots.org is a non-profit initiative of leading paediatric anaesthesiologists. We promote safe conduct of anaesthesia in children.
(Supported by an educational grant from Primex Pharmaceuticals)
A standardized quality improvement tool from the International Committee for the Advancement of Procedural Sedation.